Zhu et al., in their study on adult male SD rats and BV-2 cells, pointed out that SF improved cognitive impairments induced by streptozotocin (STZ) in rats and decreased the AD pathology via modifying the PI3K/Akt/GSK3β pathway (Yang et al., 2020). The gene discussed is GSK3B; the disease is Cognitive impairment.